CONMED (NYSE:CNMD) Raised to Hold at StockNews.com

StockNews.com upgraded shares of CONMED (NYSE:CNMD – Free Report) from a sell rating to a hold rating in a report issued on Wednesday. Several other analysts have also recently commented on CNMD. KeyCorp boosted their price target on CONMED from $131.00 to $141.00 and gave the stock an overweight rating in a research report on […]

Leave a Reply

Your email address will not be published.

Previous post The Goldman Sachs Group Lowers ZoomInfo Technologies (NASDAQ:ZI) to Neutral
Next post Former Chicago White Sox closer Bobby Jenks named manager of the Windy City ThunderBolts